Dr. Reddy's Laboratories (RDY) shares fall 8% in Wednesday trading after it posted Q1 earnings of $0.06 per share, down from 0.18 a year ago.
Factset analysts expected $0.09.
For the quarter ended June 30, the company posted revenue of $853 million.
Factset analysts expected $848.8.
Price: $11.41, Change: $-1.15, Percent Change: -9.16%